Development of an enzyme-linked immunosorbent assay for newborns dried blood spot thyroglobulin

Background: Thyroglobulin (Tg) is a biomarker of iodine status. Newborn Tg is a more sensitive marker than neonatal TSH in detecting variations in iodine intake. This study aims to validate an enzyme-linked immunosorbent assay (ELISA) for Tg determination on dried blood spots (DBS) in newborns. This...

Full description

Saved in:
Bibliographic Details
Main Authors: Camilo Fuentes Peña, María Cecilia Opazo, Luis Méndez, Claudia Riedel, Bernard Hauquier, Lionel Marcelis, Frédéric Cotton, Rodrigo Moreno-Reyes
Format: Article
Language:English
Published: Bioscientifica 2024-11-01
Series:European Thyroid Journal
Subjects:
Online Access:https://etj.bioscientifica.com/view/journals/etj/13/6/ETJ-24-0142.xml
Tags: Add Tag
No Tags, Be the first to tag this record!
_version_ 1850225884209872896
author Camilo Fuentes Peña
María Cecilia Opazo
Luis Méndez
Claudia Riedel
Bernard Hauquier
Lionel Marcelis
Frédéric Cotton
Rodrigo Moreno-Reyes
author_facet Camilo Fuentes Peña
María Cecilia Opazo
Luis Méndez
Claudia Riedel
Bernard Hauquier
Lionel Marcelis
Frédéric Cotton
Rodrigo Moreno-Reyes
author_sort Camilo Fuentes Peña
collection DOAJ
description Background: Thyroglobulin (Tg) is a biomarker of iodine status. Newborn Tg is a more sensitive marker than neonatal TSH in detecting variations in iodine intake. This study aims to validate an enzyme-linked immunosorbent assay (ELISA) for Tg determination on dried blood spots (DBS) in newborns. This study also sets out to assess the stability of Tg and the influence of newborns’ hematocrit on Tg determination. Methods: A commercially available ELISA Tg assay was adapted for use on DBS. DBS-Tg in cord blood was measured in 209 newborns delivered from healthy euthyroid pregnant women. Sensitivity, linearity, repeatability, and intermediate fidelity were determined using the appropriate standards and quality control materials. Results: The limit of detection of the DBS-Tg assay was 2.4 μg/L, and the limit of quantification was 5.8 μg/L. Repeatability and intermediate fidelity were 7.7–8.3% and 11.0–11.2%, respectively. The median cord plasma Tg and DBS-Tg values in newborns were not significantly different, 30.2 (21.3–44.4) μg/L and 31.6 (19.3–48.7) μg/L (P = 0.48) with the ELISA, respectively, and 76.5 (40.0–101.5) μg/L with the Elecsys assay with an R = 0.88. DBS-Tg concentrations decrease with increasing hematocrit values (P < 0.05). DBS-Tg values were stable at a concentration of 25 μg/L for 12 months at −20ºC and 4ºC. Conclusion: This DBS-Tg assay demonstrated good analytical performance over a wide range of Tg concentrations, suggesting it is well suited to detecting variations in Tg concentrations. Studies comparing populations with different prevalence of anemia should consider the effect of hematocrit on DBS-Tg determination. The availability of a DBS-Tg assay for newborns makes it possible to integrate iodine status monitoring with newborn screening for inherited metabolic diseases.
format Article
id doaj-art-e931cf621ca64582b9c0763f831b1fbf
institution OA Journals
issn 2235-0802
language English
publishDate 2024-11-01
publisher Bioscientifica
record_format Article
series European Thyroid Journal
spelling doaj-art-e931cf621ca64582b9c0763f831b1fbf2025-08-20T02:05:13ZengBioscientificaEuropean Thyroid Journal2235-08022024-11-01136110https://doi.org/10.1530/ETJ-24-0142Development of an enzyme-linked immunosorbent assay for newborns dried blood spot thyroglobulinCamilo Fuentes Peña0María Cecilia Opazo1Luis Méndez2Claudia Riedel3Bernard Hauquier4Lionel Marcelis5Frédéric Cotton6Rodrigo Moreno-Reyes7Department of Nuclear Medicine, Hôpital Universitaire de Bruxelles (H.U.B) - Hôpital Erasme, Brussels, BelgiumInstituto de Ciencias Naturales, Facultad de Medicina Veterinaria y Agronomía, Universidad de Las Américas, Santiago, Providencia, ChileMillennium Institute on Immunology and Immunotherapy, Facultad de Ciencias de la Vida, Universidad Andrés Bello, Santiago, ChileMillennium Institute on Immunology and Immunotherapy, Facultad de Ciencias de la Vida, Universidad Andrés Bello, Santiago, ChileDepartment of Nuclear Medicine, Hôpital Universitaire de Bruxelles (H.U.B) - Hôpital Erasme, Brussels, BelgiumLaboratory of Paediatric Research, Université Libre de Bruxelles, Brussels, BelgiumDepartament of Clinical Chemistry, LHUB-ULB, Université Libre de Bruxelles, Brussels, BelgiumÉcole de Santé Publique, Université Libre de Bruxelles, Brussels, BelgiumBackground: Thyroglobulin (Tg) is a biomarker of iodine status. Newborn Tg is a more sensitive marker than neonatal TSH in detecting variations in iodine intake. This study aims to validate an enzyme-linked immunosorbent assay (ELISA) for Tg determination on dried blood spots (DBS) in newborns. This study also sets out to assess the stability of Tg and the influence of newborns’ hematocrit on Tg determination. Methods: A commercially available ELISA Tg assay was adapted for use on DBS. DBS-Tg in cord blood was measured in 209 newborns delivered from healthy euthyroid pregnant women. Sensitivity, linearity, repeatability, and intermediate fidelity were determined using the appropriate standards and quality control materials. Results: The limit of detection of the DBS-Tg assay was 2.4 μg/L, and the limit of quantification was 5.8 μg/L. Repeatability and intermediate fidelity were 7.7–8.3% and 11.0–11.2%, respectively. The median cord plasma Tg and DBS-Tg values in newborns were not significantly different, 30.2 (21.3–44.4) μg/L and 31.6 (19.3–48.7) μg/L (P = 0.48) with the ELISA, respectively, and 76.5 (40.0–101.5) μg/L with the Elecsys assay with an R = 0.88. DBS-Tg concentrations decrease with increasing hematocrit values (P < 0.05). DBS-Tg values were stable at a concentration of 25 μg/L for 12 months at −20ºC and 4ºC. Conclusion: This DBS-Tg assay demonstrated good analytical performance over a wide range of Tg concentrations, suggesting it is well suited to detecting variations in Tg concentrations. Studies comparing populations with different prevalence of anemia should consider the effect of hematocrit on DBS-Tg determination. The availability of a DBS-Tg assay for newborns makes it possible to integrate iodine status monitoring with newborn screening for inherited metabolic diseases.https://etj.bioscientifica.com/view/journals/etj/13/6/ETJ-24-0142.xmlthyroglobulindried blood spotiodineelisanewborn
spellingShingle Camilo Fuentes Peña
María Cecilia Opazo
Luis Méndez
Claudia Riedel
Bernard Hauquier
Lionel Marcelis
Frédéric Cotton
Rodrigo Moreno-Reyes
Development of an enzyme-linked immunosorbent assay for newborns dried blood spot thyroglobulin
European Thyroid Journal
thyroglobulin
dried blood spot
iodine
elisa
newborn
title Development of an enzyme-linked immunosorbent assay for newborns dried blood spot thyroglobulin
title_full Development of an enzyme-linked immunosorbent assay for newborns dried blood spot thyroglobulin
title_fullStr Development of an enzyme-linked immunosorbent assay for newborns dried blood spot thyroglobulin
title_full_unstemmed Development of an enzyme-linked immunosorbent assay for newborns dried blood spot thyroglobulin
title_short Development of an enzyme-linked immunosorbent assay for newborns dried blood spot thyroglobulin
title_sort development of an enzyme linked immunosorbent assay for newborns dried blood spot thyroglobulin
topic thyroglobulin
dried blood spot
iodine
elisa
newborn
url https://etj.bioscientifica.com/view/journals/etj/13/6/ETJ-24-0142.xml
work_keys_str_mv AT camilofuentespena developmentofanenzymelinkedimmunosorbentassayfornewbornsdriedbloodspotthyroglobulin
AT mariaceciliaopazo developmentofanenzymelinkedimmunosorbentassayfornewbornsdriedbloodspotthyroglobulin
AT luismendez developmentofanenzymelinkedimmunosorbentassayfornewbornsdriedbloodspotthyroglobulin
AT claudiariedel developmentofanenzymelinkedimmunosorbentassayfornewbornsdriedbloodspotthyroglobulin
AT bernardhauquier developmentofanenzymelinkedimmunosorbentassayfornewbornsdriedbloodspotthyroglobulin
AT lionelmarcelis developmentofanenzymelinkedimmunosorbentassayfornewbornsdriedbloodspotthyroglobulin
AT fredericcotton developmentofanenzymelinkedimmunosorbentassayfornewbornsdriedbloodspotthyroglobulin
AT rodrigomorenoreyes developmentofanenzymelinkedimmunosorbentassayfornewbornsdriedbloodspotthyroglobulin